Q4 2023 Holdings
Filed 2024-02-14 | 33 holdings | $625.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $168.0M | 2,806,980 | 26.9% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $63.2M | 2,673,750 | 10.1% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $47.1M | 2,369,000 | 7.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $39.8M | 1,284,000 | 6.4% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $35.7M | 1,868,000 | 5.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $28.5M | 706,800 | 4.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $28.1M | 707,526 | 4.5% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $28.0M | 2,494,000 | 4.5% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $23.7M | 1,241,300 | 3.8% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $16.9M | 414,000 | 2.7% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $16.4M | 2,060,100 | 2.6% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $13.6M | 664,575 | 2.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $13.5M | 620,000 | 2.2% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $11.5M | 273,289 | 1.8% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $10.5M | 792,945 | 1.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $9.7M | 116,000 | 1.5% |
| Annexon Inc(ANNX) | COM | 03589W102 | $9.3M | 2,050,000 | 1.5% |
| Aerovate Therapeutics Inc | COM | 008064107 | $9.1M | 403,685 | 1.5% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $8.4M | 9,187,883 | 1.3% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $7.3M | 292,000 | 1.2% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $7.1M | 3,000,000 | 1.1% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $6.0M | 596,611 | 1.0% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $5.8M | 554,000 | 0.9% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $3.6M | 2,250,000 | 0.6% |
| Jasper Therapeutics Inc | COM | 471871103 | $3.5M | 4,468,114 | 0.6% |
| Veru Inc(VERUEUR) | COM | 92536C103 | $2.7M | 3,800,000 | 0.4% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $2.6M | 120,000 | 0.4% |
| Inozyme Pharma Inc | COM | 45790W108 | $1.7M | 400,000 | 0.3% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $1.5M | 1,000,000 | 0.2% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $981.8K | 1,785,000 | 0.2% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $738.0K | 25,000 | 0.1% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $456.5K | 50,000 | 0.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $105.0K | 100,000 | 0.0% |